Loss of myeloid lipoprotein lipase exacerbates adipose tissue fibrosis with collagen VI deposition and hyperlipidemia in leptin-deficient obese mice is a research paper published in Journal of Biological Chemistry (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Eli Lilly and Company
Grant: 73029
Eli Lilly and Company
Grant: HL45095
Japan Society for the Promotion of Science
Grant: JP16K21318
NHLBI NIH HHS
Grant: R01 HL045095
NHLBI NIH HHS
Grant: P01 HL151328
NHLBI NIH HHS
Grant: R37 HL045095
National Institutes of Health
Grant: 3R01HL045095-03S1
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY
Novartis Pharma
Novo Nordisk Pharma
Astellas Pharma
Pfizer Japan
Sanofi K.K.
Teijin Pharma
Jichi Medical University
Ministry of Education, Culture, Sports, Science and Technology
National Institutes of Health
Dainippon Sumitomo Pharma
MSD K.K.
National Heart, Lung, and Blood Institute
FWCI
0.73
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords